The TIL Therapies market within the context of Oncology Drugs is a rapidly growing field of research and development. TIL stands for Tumor Infiltrating Lymphocytes, which are a type of immune cell that can be used to fight cancer. TIL therapies involve extracting these cells from a patient's tumor, expanding them in the laboratory, and then re-injecting them back into the patient. This type of therapy has been shown to be effective in treating certain types of cancer, such as melanoma and ovarian cancer. TIL therapies are still in the early stages of development, but they have the potential to revolutionize the way cancer is treated. The market for TIL therapies is expected to grow significantly in the coming years as more research is conducted and more clinical trials are conducted. Some of the companies in the TIL Therapies market include Adaptimmune, Atara Biotherapeutics, Bellicum Pharmaceuticals, and Kite Pharma. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
